OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ALTUV59

Bio-UV Group SA

Electrical Components & EquipmentVerified

Capital Structure and Liquidity Bio-UV Group SA has a liquidity profile that could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company reported operating cash flow of EUR 4.6 million in the latest period. No valuation multiples or liquidity ratios are available for further analysis. ### Profitability and Returns The company's profitability metrics are not available in the current dataset. However, the operating cash flow of EUR 4.6 million suggests some level of operational efficiency. A detailed comparison with industry medians is not possible due to the lack of normalized financial data. ### Segments and Geographic Exposure Bio-UV Group SA operates in two main segments: Individual and Professionals. The Individual segment includes residential pools, spas, fish ponds, and domestic drinking water treatment, while the Professionals segment includes commercial pools, water treatment, and aquaculture. The geographic exposure is not detailed in the provided data, but the company is based in France, indicating a potential concentration in European markets. ### Growth Trajectory The company's growth trajectory is not quantified in the provided data. Analysts have provided a mean price target of EUR 2.50, with a strong-buy recommendation from one analyst and no buy or hold recommendations. This suggests a positive outlook from the analyst community, but no specific revenue growth projections are available. ### Risk Factors The primary risk for Bio-UV Group SA is liquidity risk, which could not be assessed due to the lack of balance-sheet data. The dilution risk is rated as low, with no near-term pressure expected. No specific dilution sources are identified in the provided data. The company's exposure to regulatory and geopolitical risks is not quantified in the dataset. ### Recent Events No recent events, filings, or transcripts are provided in the dataset to inform the company's recent developments or strategic direction.

30-day price · ALTUV(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyBio-UV Group SA
TickerALTUV.PA
SectorIndustrials
BusinessIndustrial Goods
Industry groupIndustrial Goods
IndustryElectrical Components & Equipment
AI analysis

Business. Bio-UV Group SA designs, manufactures, and markets ultraviolet light water treatment equipment for residential and commercial applications, including swimming pools, spas, and drinking water treatment.

Classification. The company is classified under the Industrials sector, Industrial Goods business sector, and Electrical Components & Equipment industry with a confidence level of 0.92.

### Capital Structure and Liquidity Bio-UV Group SA has a liquidity profile that could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company reported operating cash flow of EUR 4.6 million in the latest period. No valuation multiples or liquidity ratios are available for further analysis. ### Profitability and Returns The company's profitability metrics are not available in the current dataset. However, the operating cash flow of EUR 4.6 million suggests some level of operational efficiency. A detailed comparison with industry medians is not possible due to the lack of normalized financial data. ### Segments and Geographic Exposure Bio-UV Group SA operates in two main segments: Individual and Professionals. The Individual segment includes residential pools, spas, fish ponds, and domestic drinking water treatment, while the Professionals segment includes commercial pools, water treatment, and aquaculture. The geographic exposure is not detailed in the provided data, but the company is based in France, indicating a potential concentration in European markets. ### Growth Trajectory The company's growth trajectory is not quantified in the provided data. Analysts have provided a mean price target of EUR 2.50, with a strong-buy recommendation from one analyst and no buy or hold recommendations. This suggests a positive outlook from the analyst community, but no specific revenue growth projections are available. ### Risk Factors The primary risk for Bio-UV Group SA is liquidity risk, which could not be assessed due to the lack of balance-sheet data. The dilution risk is rated as low, with no near-term pressure expected. No specific dilution sources are identified in the provided data. The company's exposure to regulatory and geopolitical risks is not quantified in the dataset. ### Recent Events No recent events, filings, or transcripts are provided in the dataset to inform the company's recent developments or strategic direction.
Key takeaways
  • Bio-UV Group SA operates in the ultraviolet water treatment equipment market, targeting both residential and commercial applications.
  • Analysts have provided a strong-buy recommendation with a mean price target of EUR 2.50, indicating a positive outlook.
  • The company's liquidity risk could not be assessed due to the lack of balance-sheet data.
  • The company's growth trajectory and revenue projections are not detailed in the provided data.
  • The company is classified under the Industrials sector with a high confidence level.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyEUR
Revenue$35.9M
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow$4.6M
CapEx-$1.6M
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue-4.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Industrial Goods · cohort 13 companies
MetricALTUVActivity
Op margin9.4% medp25 9.4% · p75 9.4%
Net margin5.8% medp25 5.8% · p75 5.8%
Gross margin26.9% medp25 26.9% · p75 26.9%
R&D / revenue2.0% medp25 1.6% · p75 3.0%
CapEx / revenue-4.5%2.4% medp25 1.6% · p75 3.3%bottom quartile
Debt / equity106.4% medp25 106.4% · p75 106.4%
Observations
IR observations
Mean price target2.50 EUR
Median price target2.50 EUR
High price target2.50 EUR
Low price target2.50 EUR
Mean recommendation1.00 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count0.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.09 EUR
Last actual EPS0.08 EUR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-03 22:38 UTC#c0ff1769
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 22:39 UTCJob: 9f2056e2